Successful radiopeptide targeting of metastatic anaplastic meningioma: case report

Riferimento: 
Radiat Oncol. 2011 Aug 12;6:94.
Autori: 
Sabet A1, Ahmadzadehfar H, Herrlinger U, Wilinek W, Biersack HJ, Ezziddin S.
Fonte: 
Radiat Oncol. 2011 Aug 12;6:94.
Anno: 
2011
Azione: 
Meningioma anaplastici e metastasi polmonari, resistenti al trattamento convenzionale, sono stati sottoposti a terapia con radiopeptide 177Lu-DOTA-octreotate.
Target: 
177Lu-DOTA-octreotate/meningioma anaplastici - metastasi polmonari.

ABSTRACT
A patient with anaplastic meningioma and lung metastases resistant to conventional treatment underwent radiopeptide therapy with 177Lu- DOTA-octreotate in our institute. The treatment resulted in significant improvement in patient's quality of life and inhibition of tumor progression. This case may eventually help to establish the value of radiopeptide therapy in patients with this rare condition.
Free PMC Article